Analyst firms · Morgan Stanley · EVFM

Morgan Stanley EVFM price target and rating history

Evofem Biosciences Inc. (EVFM) · Health Care

Morgan Stanley rates Evofem Biosciences Inc. (EVFM) Underweight with a $0.53 price target, as of its latest action on Mar 4, 2022. It has published 3 rating actions on EVFM since August 2021, including 0 upgrades and 1 downgrade.

Current rating
Underweight
Price target
$0.53
Median target, all firms
Too few
Actions on EVFM
3

Morgan Stanley price target on EVFM

$1$0.77$0.5320222023202420252026
Morgan Stanley price target on EVFM, each point a stated target, August 2021 to March 2022.

Every Morgan Stanley rating on EVFM

Questions about Morgan Stanley and EVFM

What is Morgan Stanley's price target for EVFM?
Morgan Stanley's latest stated price target for Evofem Biosciences Inc. (EVFM) is $0.53, from its action on Mar 4, 2022.
What is Morgan Stanley's rating on EVFM?
Morgan Stanley rates EVFM Underweight, a bearish rating, as of Mar 4, 2022.
When did Morgan Stanley last change its view on EVFM?
On Mar 4, 2022, Morgan Stanley raises its price target to $0.53 from $0.50, keeps Underweight.

All Morgan Stanley ratingsEVFM news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.